Repressing CD147 is a novel therapeutic strategy for malignant melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Repressing CD147 is a novel therapeutic strategy for malignant melanoma

Published:2017-02-25 Issue:15 Volume:8 Page:25806-25813
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Hu Xing¹²,Su Juan¹²,Zhou Youyou²,Xie Xiaoyun¹²,Peng Cong¹²,Yuan Zhimin³,Chen Xiang¹²

Affiliation:

1. Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China

2. Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China

3. Department of Genetics and Complex Diseases, Harvard T.H Chan School of Public Health, Boston, MA, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating genomic profiling to clinical data: assessing the impact of CD147 expression on plaque stability;Frontiers in Cardiovascular Medicine;2024-09-13

2. Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies;Cancers;2024-08-16

3. Breaking Down the Arsenal: Recent Progress in the Nanotherapeutic Strategies for Hepatocellular Carcinoma Treatment;Advanced Therapeutics;2024-07-06

4. Pseudolaric Acid B Targets CD147 to Selectively Kill Acute Myeloid Leukemia Cells;International Journal of Molecular Sciences;2024-06-13

5. Immunological Profile and Markers of Endothelial Dysfunction in Elderly Patients with Cognitive Impairments;International Journal of Molecular Sciences;2024-02-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3